Loading the company…
Loading the company…
Families: Peripheral arterial intervention.
All companies · Product and company coverage
In the last ten years FDA made 7 decisions for Cardiovascular Systems (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2018 (2). The latest was on 2022-03-01.
| Family | Decisions on record |
|---|---|
| Peripheral arterial intervention | 21 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2022-03-01 | 510(k) | K220109 | DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy System |
| 2021-09-14 | 510(k) | K210586 | Diamonback 360 Peripheral Orbital Atherectomy System, Diamondback 360 Stealth Orbital Atherectomy system |
| 2020-11-19 | 510(k) | K203008 | DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy System |
| 2019-07-02 | 510(k) |
| K190634 |
| Diamondback 360 Peripheral Orbital Atherectomy System, Stealth 360 Peripheral Orbital Atherectomy System |
| 2018-12-13 | 510(k) | K182397 | Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Cardiovascular Systems.